Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease

[1] Raza JA(2004)Ischemic heart disease in women and the role of hormone therapy Int J Cardiol 96 7-19

[2] Reinhart RA(1979)Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study Diabetes Care 2 120-126

[3] Movahed A(2004)Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study Lancet 364 937-952

[4] Kannel WB(2006)Excess risk of fatal coronary heart disease associated with diabetes in men and women: metaanalysis of 37 prospective cohort studies BMJ 332 73-78

[5] McGee DL(2010)Cardiovascular risk in women with diabetes Nutr Metab Cardiovasc Dis 20 474-480

[6] Yusuf S(1998)Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837-853

[7] Hawken S(2004)Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines Circulation 110 227-239

[8] Ounpuu S(2008)The residual risk reduction initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia Am J Cardiol 102 1K-34K

[9] Huxley R(2003)Diabetic dyslipidemia: from basic research to clinical practice Diabetologia 46 733-749

[10] Barzi F(2002)Inflammation and atherosclerosis Circulation 105 1135-1143

[1] Raza JA(2004)Ischemic heart disease in women and the role of hormone therapy Int J Cardiol 96 7-19

[2] Reinhart RA(1979)Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study Diabetes Care 2 120-126

[3] Movahed A(2004)Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study Lancet 364 937-952

[4] Kannel WB(2006)Excess risk of fatal coronary heart disease associated with diabetes in men and women: metaanalysis of 37 prospective cohort studies BMJ 332 73-78

[5] McGee DL(2010)Cardiovascular risk in women with diabetes Nutr Metab Cardiovasc Dis 20 474-480

[6] Yusuf S(1998)Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837-853

[7] Hawken S(2004)Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines Circulation 110 227-239

[8] Ounpuu S(2008)The residual risk reduction initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia Am J Cardiol 102 1K-34K

[9] Huxley R(2003)Diabetic dyslipidemia: from basic research to clinical practice Diabetologia 46 733-749

[10] Barzi F(2002)Inflammation and atherosclerosis Circulation 105 1135-1143